What is the brand name of Nebivolol (beta blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bystolic is the brand name of nebivolol in the United States. Nebivolol is a beta-blocker medication primarily used to treat high blood pressure (hypertension). It works by blocking certain receptors in the heart and blood vessels, which reduces heart rate and blood pressure. Unlike some other beta-blockers, nebivolol also promotes nitric oxide release, which helps dilate blood vessels, further contributing to blood pressure reduction. This dual mechanism makes it effective for hypertension management while potentially causing fewer side effects like fatigue or sexual dysfunction compared to older beta-blockers. Nebivolol is typically prescribed in doses ranging from 5-40 mg once daily, with most patients starting at 5 mg 1. In some countries outside the US, nebivolol may be marketed under other brand names such as Neblet or Nebilet. As with all blood pressure medications, patients should take it consistently at the same time each day and should not stop taking it suddenly without medical supervision.

Some key points to consider when prescribing nebivolol include:

  • It is not recommended as a first-line agent unless the patient has ischemic heart disease (IHD) or heart failure (HF) 1.
  • Nebivolol induces nitric oxide–induced vasodilation, which is beneficial for blood pressure reduction 1.
  • Patients should avoid abrupt cessation of nebivolol to prevent rebound hypertension 1.

Overall, nebivolol is a valuable option for the management of hypertension, offering a unique mechanism of action that can provide benefits in terms of both efficacy and tolerability.

From the Research

Brand Name of Nebivolol

  • The brand name of nebivolol is Bystolic 2
  • Nebivolol is a third-generation beta-blocker used in the management of hypertension 3, 2, 4, 5, 6
  • It is a cardioselective beta-blocker with vasodilating properties, neutral metabolic effects, and good tolerability 3, 2, 4, 5, 6

Key Characteristics of Nebivolol

  • Highly selective beta(1)-receptor blocker 2, 4, 5, 6
  • Causes peripheral vasodilation by increasing the production and release of nitric oxide and decreasing nitric oxide degradation 4
  • Leads to decreases in systemic vascular resistance and large artery stiffness and possible reversal of endothelial dysfunction 4
  • Effective in lowering blood pressure and has a favorable side-effect profile 2, 4, 5, 6

Clinical Use of Nebivolol

  • Approved for the treatment of hypertension 2, 6
  • May be useful in the treatment of uncomplicated mild-to-moderate essential hypertension and in patients with heart failure 4, 5, 6
  • Has potential advantages in patients who are unable to tolerate traditional beta-blockers 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Beta-blockers in the management of hypertension: focus on nebivolol.

Expert review of cardiovascular therapy, 2008

Research

Nebivolol: a new antihypertensive agent.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Research

Nebivolol: a review of its clinical and pharmacological characteristics.

International journal of clinical pharmacology and therapeutics, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.